Inflammatory bowel disease induced by bimekizumab

Inflammatory bowel disease (IBD) is a chronic condition of the gastrointestinal tract, with a complex aetiopathogenesis in which genetic, immunological, and environmental factors are being discussed. The development of knowledge about molecular processes and the aetiology of diseases are made possib...

Full description

Saved in:
Bibliographic Details
Main Authors: Dominika Wietrzykowska-Grishanovich, Maciej Pleskacz, Radosław Kempiński
Format: Article
Language:English
Published: Termedia Publishing House 2022-05-01
Series:Gastroenterology Review
Online Access:https://www.termedia.pl/Inflammatory-bowel-disease-induced-by-bimekizumab,41,47056,1,1.html
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841548374965223424
author Dominika Wietrzykowska-Grishanovich
Maciej Pleskacz
Radosław Kempiński
author_facet Dominika Wietrzykowska-Grishanovich
Maciej Pleskacz
Radosław Kempiński
author_sort Dominika Wietrzykowska-Grishanovich
collection DOAJ
description Inflammatory bowel disease (IBD) is a chronic condition of the gastrointestinal tract, with a complex aetiopathogenesis in which genetic, immunological, and environmental factors are being discussed. The development of knowledge about molecular processes and the aetiology of diseases are made possible the implementation of modern therapies with biological drugs, which are a heterogeneous group of substances working by modulating the body’s immune response. Currently, biological medications are used in an increasing number of indications.
format Article
id doaj-art-1d7e1e463e3242cebaffdda540312690
institution Kabale University
issn 1895-5770
1897-4317
language English
publishDate 2022-05-01
publisher Termedia Publishing House
record_format Article
series Gastroenterology Review
spelling doaj-art-1d7e1e463e3242cebaffdda5403126902025-01-10T14:06:15ZengTermedia Publishing HouseGastroenterology Review1895-57701897-43172022-05-0117217517610.5114/pg.2022.11637447056Inflammatory bowel disease induced by bimekizumabDominika Wietrzykowska-GrishanovichMaciej PleskaczRadosław KempińskiInflammatory bowel disease (IBD) is a chronic condition of the gastrointestinal tract, with a complex aetiopathogenesis in which genetic, immunological, and environmental factors are being discussed. The development of knowledge about molecular processes and the aetiology of diseases are made possible the implementation of modern therapies with biological drugs, which are a heterogeneous group of substances working by modulating the body’s immune response. Currently, biological medications are used in an increasing number of indications.https://www.termedia.pl/Inflammatory-bowel-disease-induced-by-bimekizumab,41,47056,1,1.html
spellingShingle Dominika Wietrzykowska-Grishanovich
Maciej Pleskacz
Radosław Kempiński
Inflammatory bowel disease induced by bimekizumab
Gastroenterology Review
title Inflammatory bowel disease induced by bimekizumab
title_full Inflammatory bowel disease induced by bimekizumab
title_fullStr Inflammatory bowel disease induced by bimekizumab
title_full_unstemmed Inflammatory bowel disease induced by bimekizumab
title_short Inflammatory bowel disease induced by bimekizumab
title_sort inflammatory bowel disease induced by bimekizumab
url https://www.termedia.pl/Inflammatory-bowel-disease-induced-by-bimekizumab,41,47056,1,1.html
work_keys_str_mv AT dominikawietrzykowskagrishanovich inflammatoryboweldiseaseinducedbybimekizumab
AT maciejpleskacz inflammatoryboweldiseaseinducedbybimekizumab
AT radosławkempinski inflammatoryboweldiseaseinducedbybimekizumab